Machine learning-based prediction of diabetic patients using blood routine data.
Honghao Li1, Dongqing Su1, Xinpeng Zhang1
1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.
Methods (San Diego, Calif.)
|July 17, 2024
Summary
This study developed an advanced computational framework using machine learning to predict diabetes risk. The eXtreme Gradient Boosting (XGBoost) model achieved high accuracy, identifying key blood indicators for early diabetes detection.
Area of Science:
- Computational biology
- Medical informatics
- Data science in healthcare
Background:
- Diabetes is a widespread chronic disease often diagnosed late.
- Conventional diagnostic methods may miss early-stage diabetes.
- There is a need for improved, timely diabetes detection methods.
Purpose of the Study:
- To develop and validate a computational framework for early diabetes prediction.
- To identify key hematological indicators associated with diabetes.
- To create a tool for preliminary diabetes risk assessment.
Main Methods:
- Collected blood routine data from 1000 diabetes patients and 1000 healthy individuals.
- Employed machine learning algorithms: eXtreme Gradient Boosting (XGBoost), random forest, support vector machine, and elastic net.
- Utilized Shapley additive explanations (SHAP) for model interpretability and logistic regression for nomogram creation.
Main Results:
- The XGBoost model demonstrated superior predictive performance (AUC 99.90% training, 98.51% testing).
- External validation achieved an overall accuracy of 81.54%.
- Identified key predictors: MCHC, LY%, RDW-SD, and MCH.
Conclusions:
- The developed XGBoost model offers a highly effective tool for diabetes prediction.
- SHAP analysis revealed crucial hematological markers for diabetes risk.
- A logistic regression-based nomogram can aid in preliminary clinical diabetes assessment.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Errors occurring during blood pressure monitoring
675
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
675
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Pathophysiology of Diabetes
915
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
915


